Entering text into the input field will update the search result below

Takeda Pharmaceutical Company Limited (TAK) Q1 2023 Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Takeda Pharmaceutical Company Limited (NYSE:TAK) Q1 2023 Results Earnings Conference Call July 27, 2023 6:00 AM ET

Company Participants

Christopher O'Reilly - Head, Investor Relations

Christophe Weber - President and Chief Executive Officer

Andy Plump - President, Research and Development

Costa Saroukos - Chief Financial Officer

Julie Kim - President, U.S. Business Unit and U.S. Country Head

Ramona Sequeira - President, Global Portfolio Division

Conference Call Participants

Hidemaru Yamaguchi - Citigroup

Seiji Wakao - J.P. Morgan

Kazuaki Hashiguchi - Daiwa Securities

Michael Nedelcovych - TD Cowen

Shinichiro Muraoka - Morgan Stanley

Stephen Barker - Jefferies (Japan) Limited

Christopher O'Reilly

Thank you very much for joining us today despite a very busy schedule for this FY 2023 Q1 earnings announcement. My name is O'Reilly. I am the head of IR. I'll be the master of ceremony for today's meeting.

[Operator Instructions].

Before starting, I'd like to remind everyone that we will be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in our most recent Form 20-F and in our other SEC filings.

Please also refer to the important notice on the page 2 of the presentation regarding forward-looking statements and our non-IFRS financial measures, which will also be discussed during this call. Definitions of our non-IFRS measures and reconciliations with comparable IFRS financial measures are included in the appendix in the presentation.

I should also note the important notices are attached to the presentation material.

Now we're going to start the presentation. Today, we have President CEO, Christophe Weber; R&D President, Andy Plump; Chief Financial Officer, Costa Saroukos, presenting to you. This will be followed by Q&A session.

Now we'd like to

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About TAK

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on TAK

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.